Effect of Dry Needling In Paraplegics
Not Applicable
Completed
- Conditions
- Health Condition 1: G822- Paraplegia
- Registration Number
- CTRI/2021/09/036635
- Lead Sponsor
- Sancheti Institute College of Physiotherapy
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 40
Inclusion Criteria
Paraplegia for more than 6 months
Incomplete SCI of both Traumatic and Non-traumatic type
Spasticity >=1 on MAS of lower limb muscle group
Patients able to walk atleast 10m with or without Assistive devices.
Exclusion Criteria
Patients with recent orthopedic conditions which affects the mobility.
Any other Neurological Brain diagnosis
Patients with excessive fear of needle administration
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Modified Tardieu Scale for Muscle Tone <br/ ><br> <br/ ><br>10MWT for Functional MobilityTimepoint: Pre and Post Intervention
- Secondary Outcome Measures
Name Time Method ot ApplicableTimepoint: NA
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie dry needling's impact on muscle tone in paraplegia?
How does dry needling compare to standard physiotherapy interventions for paraplegic mobility function?
Are there specific biomarkers that predict paraplegic patient response to dry needling therapy?
What adverse events are associated with dry needling in paraplegic populations and how are they managed?
What combination therapies with dry needling show promise for improving spasticity in paraplegia?